InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

Current share price for SHL : $22.830 0.02 (0.09%)+

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11,283 Sonic to acquire German laboratory business of Labco 26 Sep 2013 11:50AM $15.940 $22.830 risen by 43.22%
$11,283 CEO Presentation Full Year Results to 30 June 2013 20 Aug 2013 9:54AM $15.410 $22.830 risen by 48.15%
$11,283 Preliminary Final Report 20 Aug 2013 9:32AM $15.410 $22.830 risen by 48.15%
$11,283 Half Yearly Report and Accounts 19 Feb 2013 9:21AM $12.850 $22.830 risen by 77.67%
$11,283 German Fees Update 13 Dec 2012 11:39AM $13.140 $22.830 risen by 73.74%
$11,283 Sonic Healthcare 2012 AGM Managing Director's Presentation 22 Nov 2012 9:00AM $12.850 $22.830 risen by 77.67%
$11,283 Australian Pathology Announcement 20 Nov 2012 9:19AM $13.200 $22.830 risen by 72.95%
$11,283 Termination of part of Healthscope pathology acquisition 17 Sep 2012 1:13PM $12.880 $22.830 risen by 77.25%
$11,283 Preliminary Final Report 21 Aug 2012 8:52AM $12.820 $22.830 risen by 78.08%
$11,283 Sonic to acquire Healthscope assets 16 May 2012 8:31AM $12.830 $22.830 risen by 77.94%
$11,283 Half Yearly Report and Accounts 21 Feb 2012 9:26AM $11.380 $22.830 risen by 100.62%
$11,283 2011 AGM CEO Presentation 18 Nov 2011 9:35AM $11.470 $22.830 risen by 99.04%
$11,283 Managing Director Presentation FY11 August 2011 23 Aug 2011 9:08AM $11.290 $22.830 risen by 102.21%
$11,283 Preliminary Final Report 23 Aug 2011 9:02AM $11.290 $22.830 risen by 102.21%
$11,283 Australian Pathology Funding Agreement 11 Apr 2011 8:28AM $12.630 $22.830 risen by 80.76%
$11,283 Half Yearly Report and Accounts 22 Feb 2011 8:25AM $11.370 $22.830 risen by 100.79%
$11,283 SHL Acquires Second Californian Laboratory 7 Feb 2011 9:01AM $11.830 $22.830 risen by 92.98%
$11,283 Sonic Completes 3 Synergistic Acquisitions in Belgium and US 17 Jan 2011 9:38AM $12.020 $22.830 risen by 89.93%
$11,283 Sonic Healthcare to raise USD250M of long term debt finance 3 Dec 2010 9:49AM $11.860 $22.830 risen by 92.50%
$11,283 SHL to acquire CBLPath 8 Nov 2010 9:34AM $10.930 $22.830 risen by 108.87%
$11,283 Preliminary Final Report 24 Aug 2010 9:43AM $10.800 $22.830 risen by 111.39%
$11,283 Market Update 23 July 2010 23 Jul 2010 11:05AM $10.070 $22.830 risen by 126.71%
$11,283 Sonic Healthcare Earnings Update 20 May 2010 4:35PM $10.070 $22.830 risen by 126.71%
$11,283 Half Yearly Report and Accounts 23 Feb 2010 9:23AM $14.200 $22.830 risen by 60.77%
$11,283 Acquisition of Medhold Group in Belgium 5 Feb 2010 9:27AM $14.430 $22.830 risen by 58.21%

751 - 775 of 834 results

Page 31 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.